Our Guidance Papers are ready for discussion

PATHWAY-27 consortium has developed two guidance papers:

  • The 'Scientific Guidelines' highlight best practices when designing and running randomised controlled intervention trials, which aim to demonstrate the claimed effect and are a requirement of health claim dossiers.
  • The 'Industry Guidelines' are intended as a practical guide from product development to the submission of a health claim dossier.

After several rounds of internal discussions, they are finally ready for open discuisson.

Check the details on the PATHWAY-27 Guidance Paper Workshops, by cliking here